Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue
The proposed buyout of contract drug manufacturer Catalent won’t raise competition concerns, the European Commission said.
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
‘King Kong’ of weight loss jabs set to hit Irish market as soon as next year
A NEW weight loss jabs dubbed the “King Kong” is set to hit the Irish market as soon as next year. Mounjaro can be used to ...
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars
Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year, as it scrambles to meet soaring demand for its weight ...
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments — Update
Eli Lilly said it would invest $3 billion to expand a recently acquired manufacturing facility to meet growing demand for its diabetes and weight-loss medicines. The drugmaker said the Kenosha County, ...
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Eli Lilly said it would invest $3 billion to expand a recently acquired manufacturing facility to meet growing demand for its diabetes and weight-loss medicines.
Lilly to Boost Weight-Loss Drug Supply With $3 Billion Expansion
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its ...
Hosted on MSN4d
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in weight-loss drugs.
Brooks Nader admits she used Ozempic before Dancing With The Stars but quit over common side-effect
Brooks admitted that when she was taking Ozempic she 'lost a little bit of the motivation and the strength to work out.' ...
Lilly's Head-To-Head Data Lands Blow On Novo In Battle For Weight Loss Supremacy
Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.